A detailed history of Seven Mile Advisory transactions in Abbott Laboratories stock. As of the latest transaction made, Seven Mile Advisory holds 3,017 shares of ABT stock, worth $355,191. This represents 0.23% of its overall portfolio holdings.

Number of Shares
3,017
Previous 3,046 0.95%
Holding current value
$355,191
Previous $346 Million 9.45%
% of portfolio
0.23%
Previous 0.26%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$100.73 - $112.44 $2,921 - $3,260
-29 Reduced 0.95%
3,017 $313 Million
Q1 2024

May 08, 2024

BUY
$109.52 - $120.96 $16,428 - $18,144
150 Added 5.18%
3,046 $346 Million
Q4 2023

Feb 09, 2024

BUY
$90.19 - $110.4 $43,381 - $53,102
481 Added 19.92%
2,896 $319 Million
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $955 - $1,146
-10 Reduced 0.41%
2,415 $234 Million
Q2 2023

Aug 08, 2023

BUY
$100.78 - $112.29 $244,391 - $272,303
2,425 New
2,425 $264 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Seven Mile Advisory Portfolio

Follow Seven Mile Advisory and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Mile Advisory, based on Form 13F filings with the SEC.

News

Stay updated on Seven Mile Advisory with notifications on news.